Related content

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation

By Woodward W.A.   Strom E.A.   Tucker S.L.   Katz A.   McNeese M.D.   Perkins G.H.   Buzdar A.U.   Hortobagyi G.N.   Hunt K.K.   Sahin A.   Meric F.   Sneige N.   Buchholz T.A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 336-344

Elsevier

Access to resources Recommend Favorite

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

By Panoff J.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

By Graham Peter  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 353-355

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of Local Recurrence in a Population-Based Cohort of Women with Ductal Carcinoma In Situ Treated with Breast Conserving Surgery Alone

By Wai Elaine  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 119-124

Springer Publishing Company

Access to resources Recommend Favorite

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

By Herk-Sukel Myrthe  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 843-851

Springer Publishing Company

Access to resources Recommend Favorite